BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18310528)

  • 21. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y; Qian F; Wei D; Liu J
    J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A; Seth K; Kalra N; Shukla Y
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progesterone-adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux: design, synthesis, characterization and biological evaluation.
    Zeinyeh W; Mahiout Z; Radix S; Lomberget T; Dumoulin A; Barret R; Grenot C; Rocheblave L; Matera EL; Dumontet C; Walchshofer N
    Steroids; 2012 Oct; 77(12):1177-91. PubMed ID: 22868178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reversal of multidrug resistance of HL-60 adriamycin resistant leukemia cell line by quercetin and its mechanisms].
    Cai X; Chen FY; Han JY; Gu CH; Zhong H; Teng Y; Ouyang RR
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):326-9. PubMed ID: 16117892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug sensitivity assay for leukaemic cells by flow cytometry.
    Gupta M; Naik S; Pandey CM; Dabadghao S
    Indian J Med Res; 2002 Jun; 115():260-4. PubMed ID: 12440199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Vitamin K3 and K5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells.
    Nakaoka E; Tanaka S; Onda K; Sugiyama K; Hirano T
    Anticancer Res; 2015 Nov; 35(11):6041-8. PubMed ID: 26504027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
    Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC
    Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of fourteen new hydantoin compounds on the human ABCB1 efflux pump.
    Martins A; Dymek A; Handzlik J; Spengler G; Armada A; Molnar J; Kiéc-Kononowicz K; Amaral L
    In Vivo; 2012; 26(2):293-7. PubMed ID: 22351672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacophore-based drug design and biological evaluation of novel ABCB1 inhibitors.
    Zhang SL; Wei YX; Li Q; Sun HP; Peng H; You QD
    Chem Biol Drug Des; 2013 Mar; 81(3):349-58. PubMed ID: 23095256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Selection of drugs for chemotherapy based on drug resistance marker].
    Fukumoto H; Saijo N
    Nihon Rinsho; 1996 Jun; 54(6):1680-4. PubMed ID: 8691629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling drug-drug interactions of AZD1208 with Vincristine and Daunorubicin on ligand-extrusion binding TMD-domains of multidrug resistance P-glycoprotein (ABCB1).
    Marques MB; de Oliveira PV; Fagan SB; Oliveira BR; da Silva Nornberg BF; Almeida DV; Marins LF; González-Durruthy M
    Toxicology; 2019 Jan; 411():81-92. PubMed ID: 30339824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia.
    Williams MS; Amaral FM; Simeoni F; Somervaille TC
    J Clin Invest; 2020 Mar; 130(3):1217-1232. PubMed ID: 31770110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorinated β-Diketo Phosphorus Ylides Are Novel Inhibitors of the ABCB1 Efflux Pump of Cancer Cells.
    Spengler G; Ocsovszki I; Tönki ÁS; Saijo R; Watanabe G; Kawase M; Molnár J
    Anticancer Res; 2015 Nov; 35(11):5915-9. PubMed ID: 26504015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids.
    Zeino M; Paulsen MS; Zehl M; Urban E; Kopp B; Efferth T
    Biochem Pharmacol; 2015 Jan; 93(1):11-24. PubMed ID: 25451686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation.
    Khamenehfar A; Wan CP; Li PC; Letchford K; Burt HM
    Anal Bioanal Chem; 2014 Nov; 406(28):7071-83. PubMed ID: 25315452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of novel phenolic compounds with multidrug resistance (MDR) reversal properties from Onychium japonicum.
    Li MC; Yao Z; Takaishi Y; Tang SA; Duan HQ
    Chem Biodivers; 2011 Jun; 8(6):1112-20. PubMed ID: 21674783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia Model.
    Halley PD; Lucas CR; McWilliams EM; Webber MJ; Patton RA; Kural C; Lucas DM; Byrd JC; Castro CE
    Small; 2016 Jan; 12(3):308-20. PubMed ID: 26583570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening strategy may help overcome resistance.
    Cancer Discov; 2015 Jan; 5(1):OF1. PubMed ID: 25583801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orchestral role of lipid metabolic reprogramming in T-cell malignancy.
    Mehta A; Ratre YK; Soni VK; Shukla D; Sonkar SC; Kumar A; Vishvakarma NK
    Front Oncol; 2023; 13():1122789. PubMed ID: 37256177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.